Board Meeting Outcomes

The Board of Directors meeting commenced at 4:22 PM and concluded at 5:08 PM on 7th August 2026. The Board approved the following items:

1. Un-Audited Standalone Financial Results of the Company for the Quarter ended 30th June 2026

2. Limited Review Report on the Financial Results for the Quarter ended 30th June 2026

3. Approval of Postal Ballot notice for Re-designation of Dr. Arun N Palaniswami (DIN: 02706099) as Joint Managing Director of the Company

4. Approval of fixation of cut-off date for determining eligibility of shareholders for e-voting/voting for Postal Ballot event on Friday, 14th August 2026

Financial Results Summary (Quarter Ended 30th June 2026)

Income Statement (₹ in Lakhs)

Total Income: ₹43,864.92

  • Revenue from operations: ₹43,090.85
  • Other operating income: ₹39.90
  • Other income: ₹734.17

Total Expenses: ₹34,711.14

  • Cost of medicines, Hospital consumables and Dietary consumed: ₹12,344.36
  • Employee benefits expense: ₹7,915.27
  • Finance costs: ₹801.58
  • Consulting charges to Doctors: ₹6,113.75
  • Depreciation and amortization expense: ₹3,172.69
  • Other expenses: ₹4,363.49

Profit before tax: ₹9,153.78

Tax expense: ₹2,245.20

  • Current tax (Net): ₹2,212.39
  • Deferred tax: ₹32.81

Profit for the period from continuing operations: ₹6,908.58

Other comprehensive income: (₹8.96)

  • Remeasurement of post employment benefit obligations: (₹12.76)
  • Change in equity instruments measured at FVOCI: ₹0.69
  • Income tax relating to items: ₹3.11

Total Comprehensive Income for the period: ₹6,899.62

Basic and diluted earnings per share (In Rupees): ₹63.14

Comparative Financial Performance

| Particulars | Q1 FY27 (30.06.2026) | Q4 FY26 (31.03.2026) | Q1 FY26 (30.06.2025) | Full Year FY26 (31.03.2026) |

| Revenue from operations | ₹43,090.85 | ₹41,319.94 | ₹37,359.37 | ₹1,58,415.16 |

| Total Income | ₹43,864.92 | ₹42,167.02 | ₹37,960.39 | ₹1,61,388.41 |

| Profit before tax | ₹9,153.78 | ₹8,427.80 | ₹7,638.25 | ₹32,569.14 |

| Profit for the period | ₹6,908.58 | ₹6,335.32 | ₹5,722.58 | ₹24,446.00 |

| EPS (₹) | 63.14 | 57.90 | 52.30 | 223.41 |

Segment-wise Performance (₹ in Lakhs)

Revenue from operations:

  • Healthcare: ₹43,130.75 (Q1 FY27)
  • Education: Not separately quantified but included in total

Segment Results - Profit/(loss) before interest and tax:

  • Healthcare: ₹9,387.41 (Q1 FY27)
  • Education: ₹1,094.21 (Q1 FY27)
  • Sub-total: ₹10,481.62 (Q1 FY27)

Capital Employed (Segment assets - Segment liabilities):

  • Healthcare: ₹1,21,304.24 (Assets: ₹1,80,993.91; Liabilities: ₹59,689.67)
  • Education: ₹17,352.10 (Assets: ₹24,338.64; Liabilities: ₹6,986.54)
  • Unallocated: ₹169.80 (Assets: ₹7,935.90; Liabilities: ₹7,766.10)
  • Total Capital Employed: ₹1,38,826.14

Auditor's Review Report

VKS Aiyer & Co., Chartered Accountants (ICAI Firm Registration No. 000066S) issued a limited review report stating:

  • The review was conducted in accordance with Standard on Review Engagements (SRE) 2410
  • Nothing came to their attention that causes them to believe the statement contains material misstatement
  • The statement was prepared in accordance with Ind AS 34 and compliance with Regulation 33 of SEBI Listing Regulations
  • The figures for quarter ended March 31, 2026 are balancing figures between audited annual figures and published unaudited year-to-date figures

Auditor Details: VKS Aiyer & Co., Chartered Accountants, No. 380, VCR Puram, Off Alagesan Road, Saibaba Colony, Coimbatore - 641 011

UDIN: 26028328NEOUDJ3147